Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Human Factors

Date Submitted: Oct 25, 2024
Open Peer Review Period: Nov 20, 2024 - Jan 15, 2025
Date Accepted: May 27, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Finnish Registry-Based Protocol for Screening and Management of Fatigue and Cognitive Problems in Multiple Sclerosis: Observational Study

Hämäläinen P, Lämsä E, Viitala M, Kuusisto H, Niiranen M, Avikainen S, Puustinen J, Ryytty M, Ruutiainen J, Soilu-Hänninen M

Finnish Registry-Based Protocol for Screening and Management of Fatigue and Cognitive Problems in Multiple Sclerosis: Observational Study

JMIR Hum Factors 2025;12:e67990

DOI: 10.2196/67990

PMID: 40845243

PMCID: 12373260

Finnish Registry-Based Protocol for Screening and Management of Fatigue and Cognitive Problems in Multiple Sclerosis: Protocol Description and Preliminary Results

  • Päivi Hämäläinen; 
  • Elina Lämsä; 
  • Matias Viitala; 
  • Hanna Kuusisto; 
  • Marja Niiranen; 
  • Sari Avikainen; 
  • Juha Puustinen; 
  • Mervi Ryytty; 
  • Juhani Ruutiainen; 
  • Merja Soilu-Hänninen

ABSTRACT

Background:

Digital patient registries are actively used in the monitoring of long-term diseases. The potential of the registries in the management of symptoms is underutilized.

Objective:

The present paper reports the Finnish registry-based procedure to screen and manage cognitive symptoms and fatigue in multiple sclerosis (MS). The data collected during the first two years is presented.

Methods:

The Symbol Digit Modalities Test (SDMT), the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ), and the Fatigue Scale for Motor and Cognitive Functions (FSMC) were implemented into the Finnish MS registry to screen symptoms related to cognition and fatigue. For self-management purposes, feedback reports based on the results on the MSNQ and the FSMC were created. To assess patient-perceived disease severity, disability, and quality of life (QoL), the Patient-Reported Expanded Disability Status Scale (PREDSS), the Visual Analogue Scales (VAS), and the Euro Quality of Life – 5 Dimension (EQ-5D) were implemented into the registry.

Results:

At the end of 2020, Finnish procedure to screen and manage patient-perceived concerns related to cognition and fatigue together with self-assessment of disease status, symptoms, and QoL annually was introduced. By the beginning of 2023, 134 patients have been assessed with the SDMT. 329 patients have filled out the FSMC and 172 patients the MSNQ at least once and have received the corresponding feedback reports. The mean SDMT score is 49.6, MSNQ score 35.3, total FSMC score 63.0, and sub-score for motor and cognitive fatigue 31.6 and 31.5, respectively.

Conclusions:

The Finnish MS registry offers a digital platform for systematic screening and self-management of fatigue and cognitive problems in MS. Patient registries should be better recognized as e-Health solutions.


 Citation

Please cite as:

Hämäläinen P, Lämsä E, Viitala M, Kuusisto H, Niiranen M, Avikainen S, Puustinen J, Ryytty M, Ruutiainen J, Soilu-Hänninen M

Finnish Registry-Based Protocol for Screening and Management of Fatigue and Cognitive Problems in Multiple Sclerosis: Observational Study

JMIR Hum Factors 2025;12:e67990

DOI: 10.2196/67990

PMID: 40845243

PMCID: 12373260

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.